The US Food and Drug Administration (FDA) may announce its decision allowing emergency use authorization of an antiviral drug to treat coronavirus patients as early as Wednesday. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leaving hospital in two weeks, reported The New … Read more
A trial of the antiviral drug remdesivir has produced ‘positive data’ for treating coronavirus patients, its maker, Gilead Sciences, said Wednesday. Gilead announced the results of a clinical trial testing the drug, which was originally developed to treat Ebola patients, in people severely ill with coronavirus. Half of the 397 patients, who were sick enough … Read more
A trial of the antiviral drug remesivir has resulted ‘positive data’ for treating coronavirus patients, its maker, Gilead Sciences, said Wednesday. Gilead was expected this week to announce the results of a clinical trial testing the drug, which was originally developed to treat Ebola patients, in people severely ill with coronavirus. Half of the 397 … Read more
Remdesivir anti-viral trial reports ‘rapid recoveries’ for severe hospitalised coronavirus patients with ‘nearly all’ discharged within a week. University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients were been treated with daily infusions of remdesivir. Most of them … Read more